BFSG »

Actinium Pharmaceuticals shares owned by BFSG

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by BFSG

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.9k 500 7.83
2023-12-31 $2.5k 500 5.08

More positions owned by BFSG

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard World Energy Etf (VDE)
Ishares Gold Tr Ishares New (IAU)
Church & Dwight (CHD)
CSX Corporation (CSX)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Vanguard Bd Index Fds Short Trm Bond (BSV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Raytheon Technologies Corp (RTX)
Exxon Mobil Corporation (XOM)
Costco Wholesale Corporation (COST)

View all positions for BFSG

Top funds holding Actinium Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Brandywine Global Investment Management
Citadel Advisors
Charles Schwab Investment Management
Bank of New York Mellon
Royce & Associates
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Jane Street
Creative Financial Designs
Virtu Financial
Jpmorgan Chase & Co

View all funds holding Actinium Pharmaceuticals